Evommune
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
Revenue | $0 | $0 | $10,000 |
Gross Profit | -349 | -326 | 10,000 |
EBITDA | -21,325 | -27,947 | -12,164 |
EBIT | -21,674 | -28,273 | -12,475 |
Net Income | -21,674 | -28,273 | -12,475 |
Net Change In Cash | 0 | 0 | 10,000 |
Free Cash Flow | -27,586 | -16,803 | -9,766 |
Cash | 48,318 | 44,063 | 26,818 |
Basic Shares | 33,670 | 31,524 | 31,524 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $13,000 | $7,000 | $5,000 |
Gross Profit | 13,000 | 5,713 | 4,000 |
EBITDA | -67,481 | -65,487 | -32,995 |
EBIT | -68,870 | -66,774 | -33,995 |
Net Income | -68,870 | -66,808 | -34,053 |
Net Change In Cash | 13,000 | 7,000 | 5,000 |
Free Cash Flow | -76,676 | -58,283 | -30,088 |
Cash | 44,063 | 16,254 | 29,024 |
Basic Shares | 31,524 | 30,077 | 30,077 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.64 |
2025-12-31 | -$1.43 |
2025-09-30 | -$8.07 |